GliaCure’s focus on glia as targets for drug discovery has the potential to impact many other diseases of the central nervous system including traumatic brain injury, Down Syndrome, Parkinson’s disease, glioblastoma, neuropathic pain, epilepsy, psychiatric and sleep disorders.